Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/16/24 21:13 | 7/12/24 | TKNO | Health | Diagn | In Vitro & In Vivo Diagnostic | Telegraph Hill Partners Iv, L.P. | CA | T | 2 | P | 30,000 | 1.48 | 0 | 20,205 | 316 | 26,591 | I | |||||||||||||||
7/16/24 17:15 | 7/12/24 | TKNO | Health | Diagn | In Vitro & In Vivo Diagnostic | Lowell Matthew | CA | O | CFO | 2 | P | 150 | 1.59 | 0 | 94 | 278 | 128 | D | ||||||||||||||
7/16/24 17:15 | 7/12/24 | TKNO | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | 2 | P | 200 | 1.48 | 0 | 135 | 124 | 243 | D | ||||||||||||||
2/27/24 16:21 | 8/15/22 | TKNO | Health | Diagn | In Vitro & In Vivo Diagnostic | Grossman Paul David | CA | D | 1 | P.m | 50 | 5.37 | 0 | 9 | 9 | D | ||||||||||||||||
12/1/23 17:44 | 11/30/23 | TKNO | Health | Diagn | In Vitro & In Vivo Diagnostic | Gelhaus Ken | CA | O | Chief Co | 1 | P | 6 | 1.73 | 0 | 4 | 19 | 23 | D | ||||||||||||||
9/21/23 17:04 | 9/19/23 | TKNO | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrill Damon | CA | O | GC,CCO | 1 | P | 50 | 1.85 | 0 | 27 | 193 | 41 | D | ||||||||||||||
9/21/23 17:04 | 9/19/23 | TKNO | Health | Diagn | In Vitro & In Vivo Diagnostic | Mackowski J Matthew | CA | D | 1 | P | 1,500 | 1.85 | 0 | 811 | 999% | 821 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |